tiprankstipranks
Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Australian Market

Recce Pharmaceuticals Ltd. (RCE) Income Statement

Compare
8 Followers

Recce Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2024), Recce Pharmaceuticals Ltd.'s total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Recce Pharmaceuticals Ltd.'s net income was AU$-10.20M. See Recce Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 0.00AU$ 4.37MAU$ 3.08MAU$ 1.64MAU$ 1.12M
Gross Profit
AU$ -366.77KAU$ 4.15MAU$ 2.90MAU$ 1.34MAU$ 920.91K
Operating Expenses
AU$ 21.68MAU$ 17.11MAU$ 13.96MAU$ 15.07MAU$ 5.21M
Depreciation and Amortization
AU$ 366.77KAU$ 217.16KAU$ 187.67KAU$ 295.63KAU$ 200.82K
EBITDA
AU$ -21.35MAU$ -16.99MAU$ -10.80MAU$ -14.77MAU$ -5.13M
Operating Income
AU$ -22.05MAU$ -17.33MAU$ -14.15MAU$ -15.36MAU$ -5.41M
Other Income/Expenses
AU$ -516.48KAU$ 4.25MAU$ -4.42MAU$ -1.57MAU$ -1.10M
Pretax Income
AU$ -22.57MAU$ -17.39MAU$ -14.07MAU$ -15.08MAU$ -5.39M
Net Income
AU$ -17.66MAU$ -13.08MAU$ -10.99MAU$ -13.51MAU$ -4.32M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.10AU$ -0.07AU$ -0.06AU$ -0.09AU$ -0.03
Diluted EPS
AU$ -0.10AU$ -0.07AU$ -0.06AU$ -0.09AU$ -0.03
Weighted Average Shares Outstanding
177.10M 175.71M 175.87M 156.95M 128.48M
Weighted Average Shares Outstanding (Diluted)
177.10M 175.71M 175.87M 156.95M 128.48M
Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis